We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Westpharma.com has been upgraded! The new, mobile-friendly site offers easier navigation, intuitive design and enhanced searchability. The new site is mobile-friendly, and can be easily viewed and navigated from phones and tablets.
The redesign incorporates West’s vision – By your side for a healthier world. These simple words carry a powerful message. By working side-by-side with our customers, West can help deliver life-saving therapies safely and effectively to patients.
The website redesign is just the first step in bolstering our online presence. Watch for further updates in the coming months and check back often for blog, newsletter and article updates!
Over the past several decades, IT has moved from a data-center model, where most information and data was inside the enterprise, to the Internet, where there’s more information outside the four walls of the enterprise than within it. More recently, the pervasiveness of mobility, social media, and bring your own device (BYOD) and cloud (BYOC) are bringing about both technical and cultural changes that are profoundly changing enterprise IT and computing.
West is honored to be a recipient of the 2020 Faces of Philanthropy Award from the Philadelphia Business Journal. The Faces of Philanthropy Awards honor partnerships between corporations and nonprofit organizations in the Philadelphia region as they work together to deliver impactful philanthropic initiatives.
Earlier this year, we held a free 3-day virtual workshop (4 hours per day) bringing together industry experts and thought leaders in a unique forum to address a series of challenges and practical strategies to de-risk their injectable combination product development and commercialization.
On October 20, West and President & CEO, Eric M. Green, were recognized as a Health Care Innovator by the <em>Philadelphia Business Journal</em>.
One of the challenges a drug manufacturer faces is controlling the drug product at the point-of-use in a hospital or clinical environment. Often the method of vial access is variable, leading to an increased risk of harmful patient outcomes such as stopper cores or fragments entering into the drug product, which can contribute to cardiovascular events. There are a number of causes that contribute to stopper coring and fragmentation in the field that depend primarily on the technique of the practitioner and the properties of the elastomeric closure.
English
Chinese
